918433-19-9

Basic information

• Product Name: (S)-[5-AMINO-1-(4-METHOXY-PHENYLCARBAMOYL)-PENTYL]-CARBAMIC ACID 9H-FLUOREN-9-YLMETHYL ESTER
• Synonyms: (S)-[5-AMINO-1-(4-METHOXY-PHENYLCARBAMOYL)-PENTYL]-CARBAMIC ACID 9H-FLUOREN-9-YLMETHYL ESTER
• CAS NO: 918433-19-9
• Molecular Weight: 473.572
• Mol File: 918433-19-9.mol

Chemical Properties

• CAS DataBase Reference: (S)-[5-AMINO-1-(4-METHOXY-PHENYLCARBAMOYL)-PENTYL]-CARBAMIC ACID 9H-FLUOREN-9-YLMETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-[5-AMINO-1-(4-METHOXY-PHENYLCARBAMOYL)-PENTYL]-CARBAMIC ACID 9H-FLUOREN-9-YLMETHYL ESTER(918433-19-9)
• EPA Substance Registry System: (S)-[5-AMINO-1-(4-METHOXY-PHENYLCARBAMOYL)-PENTYL]-CARBAMIC ACID 9H-FLUOREN-9-YLMETHYL ESTER(918433-19-9)

Safety Data

• Hazardous Substances Data: 918433-19-9(Hazardous Substances Data)

Upstream product

• 104-94-9 4-methoxy-aniline 
• 71989-26-9 Fmoc-Lys(tert-butoxycarbonyl) 

Relevant articles and documents

A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor

Prostate cancer is a leading cause of cancer-related death in men and RNA interference (RNAi) has emerged as a potential therapeutic option. However, the absence of a safe and specific delivery vector remains a major obstacle to the clinical application o

COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISEASE

The present disclosure provides amide-based, non-nucleoside compounds having an inhibitory activity against endogenous polymerases, such as polymerase alpha and polymerase gamma. This disclosure further provides uses of treating hyperproliferative disease

NON-NUCLEOSIDE ANTI-HEPACIVIRUS AGENTS AND USES THEREOF

The present dislcosure provides amide-based, non-nucleoside compounds having antiviral activity against Hepacivirus, such as hepatitis C virus (HCV), methods and intermediates for synthesizing such compounds, and methods of using the compounds in a variety of contexts, including in the treatment and prevention of viral infections. The present dislcosure also provides methods for identifying amide-based, non-nucleoside compounds having antiviral activity.